Richard J Knight
Overview
Explore the profile of Richard J Knight including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
483
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yun A, Rogers A, Krisl J, Kagan A, Adrogue H, Khan A, et al.
Transplant Direct
. 2025 Mar;
11(3):e1769.
PMID: 40034162
Background: Focal segmental glomerulosclerosis (FSGS) recurs after kidney transplantation (KT) in 30%-50% of recipients. Recurrence is associated with early graft loss in up to 60% of cases. This study aimed...
2.
Knight R, Ye Y, Graviss E, Nguyen D, Garami Z, Yi S, et al.
Clin Transplant
. 2024 Jul;
38(7):e15413.
PMID: 39033508
Introduction: It is unclear whether kidney/pancreas (KP) transplantation will prevent the progression of peripheral arterial disease (PAD) in patients with insulin dependent diabetes (IDDM) and end-stage renal disease. We sought...
3.
Swan J, Rizk E, Jones S, Nwana N, Nicolas J, Tran A, et al.
PLoS One
. 2022 Dec;
17(12):e0278781.
PMID: 36534667
Background: Solid organ transplant (SOT) recipients are predicted to have worse COVID-19 outcomes due to their compromised immunity. However, this association remains uncertain because published studies have had small sample...
4.
Bae S, Alejo J, Chiang T, Werbel W, Tobian A, Moore L, et al.
Am J Transplant
. 2022 Jul;
22(12):3137-3142.
PMID: 35869809
A recent study concluded that SARS-CoV-2 mRNA vaccine responses were improved among transplant patients taking mTOR inhibitors (mTORi). This could have profound implications for vaccine strategies in transplant patients; however,...
5.
Alejo J, Mitchell J, Chiang T, Chang A, Abedon A, Werbel W, et al.
Transplantation
. 2022 Jul;
106(10):e452-e460.
PMID: 35859275
Background: Solid organ transplant recipients (SOTRs) are less likely to mount an antibody response to SARS-CoV-2 mRNA vaccines. Understanding risk factors for impaired vaccine response can guide strategies for antibody...
6.
Huang H, Yi S, Mobley C, Saharia A, Bhimaraj A, Moore L, et al.
Clin Transplant
. 2022 Jan;
36(5):e14600.
PMID: 35083796
Response to two doses of a nucleoside-modified messenger ribonucleic acid (mRNA) vaccine was evaluated in a large solid-organ transplant program. mRNA COVID-19 vaccine was administered to transplant candidates and recipients...
7.
Yi S, Moore L, Eagar T, Graviss E, Nguyen D, Ibrahim H, et al.
Transplant Direct
. 2021 Dec;
8(1):e1257.
PMID: 34912946
Background: Data about vaccine efficacy in solid organ transplant patients are limited. We previously reported our initial observation of a 6.2% immunogenicity rate in kidney transplant recipients (KTRs) after administration...
8.
Kuten S, Graviss E, Nguyen D, Gaber A, Sadhu A, Simpson E, et al.
Transplant Direct
. 2021 Nov;
7(12):e795.
PMID: 34841047
Background: Orthostatic hypotension (OH) is a poorly understood complication of simultaneous pancreas-kidney (SPK) transplantation. We sought to determine the incidence, timing, and relationship of OH to rapid glycemic control in...
9.
Knight R, Loucks-Devos J, Khan N, Nguyen D, Graviss E, Eagar T, et al.
Transplant Proc
. 2021 Jul;
53(6):1865-1871.
PMID: 34247857
Background: Renal allograft survival is negatively affected by the development of de novo posttransplant donor-specific antibodies (dnDSA). We sought to determine whether treatment with intravenous immunoglobulin (IVIG) could remove or...
10.
Yi S, Eagar T, Moore L, Huang H, Ibrahim H, Hobeika M, et al.
Transplantation
. 2021 Jun;
105(10):e133-e134.
PMID: 34155187
No abstract available.